Auction, page-15

Remember back to these days !

http://www.analyticamedical.com/downloads/2011/20111130-WiseOwl-Analytica.pdf

"The AutoStart® feature frees up to 20 minutes of nursing time per patient, per medication event. Average nurse wages in Australia are $45 per hour. As each patient may be medicated three times per day, the savings per burette may be up to $45/day, or seven times the cost of a standard burette ($6) to the hospital."

"Standard burettes require, flushing‟ with separate saline-filled syringes after IV drug delivery. The AutoFlush feature allows for flushing with saline directly from the IV bag."

"Additional flushing syringes or ampules are therefore not required, saving an estimated $2.50 per medication event. This may save 6-8 ampoules, or $18 per day. The AutoFlush is anticipated to retail for much less than the cost of the medication event, potentially saving the hospital in excess of 6-8 times the cost of the device"

The AutoStart and AutoFlush have always been no brainer technologies. The issue is, ALT have never been able to get anyone to take them on board on a large commercial scale and thus force the majors to do a deal with them before they start cornering market share

From memory, each patient needs a new burette every few day's don't they with the standard one ? That would mean the likes of Baxter would literally sell 100M's of these a year. Even if ALT sought a royalty of 50c a burette, it it still $50M in royalties. A mere 20c royalty per burette is $20M in royalties. Compared to the current market cap of <$13M, they'd be taken out before a deal is ever done

The majors have no incentive to replace their burette which has inbuilt obsolescence to ensure maximum product volume and market share, for ALT's which whilst it would save the hospitals huge $$$, results in fewer burette's having to be purchased and thus lower profits back to pharma

The need to get QLD turning over big volume to springboard them to a multinational

Hopefully one day they get there